Loading...
The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations
C-terminal mutations of CD20 constitute part of the mechanisms that resist rituximab therapy. Most CD20 having a C-terminal mutation was not recognized by L26 antibody. As the exact epitope of L26 has not been determined, expression and localization of mutated CD20 have not been completely elucidate...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3255244/ https://ncbi.nlm.nih.gov/pubmed/22829136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2011.11 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|